Linling He
13Patents
2h-index
17Co-inventors
43Inventor score
Filing activity: Jan 26, 2017 → May 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10906944B2 | Stabilized coronavirus spike (S) protein immunogens and related vaccines | Chemistry; Metallurgy | 24 | Active |
| US11097002B2 | Nanoparticle vaccines with novel structural components | Emerging Cross-Sectional Technologies | 3 | Active |
| US11845777B2 | Stabilized coronavirus spike (S) protein immunogens and related vaccines | Chemistry; Metallurgy | 1 | Active |
| US10780178B2 | Scaffolded HIV-1 vaccine immunogens | Chemistry; Metallurgy | 0 | Active |
| US12109261B1 | Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens | Chemistry; Metallurgy | 0 | Active |
| US11767347B2 | HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion envelope conformations | Chemistry; Metallurgy | 0 | Active |
| US10647748B2 | HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformations | Chemistry; Metallurgy | 0 | Active |
| US11008368B2 | Engineered HCV E2 immunogens and related vaccine compositions | Chemistry; Metallurgy | 0 | Active |
| US10934345B2 | Broadly neutralizing antibodies against HIV-1 and use thereof | Physics | 0 | Active |
| US11305004B2 | Compositions and methods related to ebolavirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US11236134B2 | Nucleic acids encoding HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformations | Chemistry; Metallurgy | 0 | Active |
| US11872277B2 | Compositions and methods related to ebolavirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US11452771B2 | Scaffolded HIV-1 Env GP140 trimer immunogen | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.